Frederick Munschauer: Using Real World Evidence to Weigh Efficacy of Treatment

While it may not be possible to compare the efficacy of treatments for multiple sclerosis in clinical trials work is being done to look at the various options through results in actual practice.

Presenting data at the annual meeting of the Consortium of Multiple Sclerosis Centers Frederick Munschauer, MD, from EMD Serono discussed this new technique for measuring results which he said could be the future of the field. By being able to study thousands of similar patients he said it is possible to see how the drugs compare in their every day lives as opposed to a limited timeframe during the trials with a limited patient population.